Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal modification protein RimK-like family member B pseudogene 2 (RIMKLBP2) is a processed pseudogene in humans. It is cataloged in gene nomenclature databases with HGNC ID: 39163 and mapped in the genome but does not encode a functional protein. Classified as a processed pseudogene, RIMKLBP2 lacks evidence of protein expression, biological activity, or established roles in disease, drug interaction, or clinical biomarker use[3][4][8][9]. This entry refers to a pseudogene, not a functional receptor, enzyme, or drug target, so it is not considered a therapeutic target and has no known biological, clinical, or pharmacological roles[3][4][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal modification protein RimK-like family member B pseudogene 2 (RIMKLBP2).